Detailed answers about CANCER RESEARCH UK SCOTLAND INSTITUTE LIMITED, including incorporation, status, business activity, and accounts information.
When was CANCER RESEARCH UK SCOTLAND INSTITUTE LIMITED founded?
CANCER RESEARCH UK SCOTLAND INSTITUTE LIMITED was officially incorporated on 29 November 2023 and is registered under company number SC790865. Incorporation establishes the company as a legal entity registered at Companies House, allowing it to trade, enter contracts, and operate under UK company law.
What type of company is CANCER RESEARCH UK SCOTLAND INSTITUTE LIMITED?
Private Limited Company. This classification indicates the legal structure of the company, which determines the way it is governed, its liability, and regulatory obligations. A private limited company (Ltd) limits the personal liability of its shareholders.
What is the current status of CANCER RESEARCH UK SCOTLAND INSTITUTE LIMITED?
CANCER RESEARCH UK SCOTLAND INSTITUTE LIMITED's current status is Active. The company status indicates whether it is actively trading, dormant, or has been dissolved. Maintaining an active status is essential for legally conducting business, filing accounts, and maintaining credibility with partners and lenders.
What does CANCER RESEARCH UK SCOTLAND INSTITUTE LIMITED do?
CANCER RESEARCH UK SCOTLAND INSTITUTE LIMITED operates in the following sector: 72190 - Other research and experimental development on natural sciences and engineering. This provides insight into the company's primary business activity and industry focus.
What is CANCER RESEARCH UK SCOTLAND INSTITUTE LIMITED's registered address?
The registered office address of CANCER RESEARCH UK SCOTLAND INSTITUTE LIMITED is GARSCUBE ESTATE, SWITCHBACK ROAD, BEARSDEN, GLASGOW, UNITED KINGDOM, G61 1BD. This is the official address filed with Companies House for legal and statutory correspondence.
Is CANCER RESEARCH UK SCOTLAND INSTITUTE LIMITED financially stable?
The most recent accounts for CANCER RESEARCH UK SCOTLAND INSTITUTE LIMITED were made up to 31 March 2025, filed as DORMANT. Next accounts are due by 31 December 2026.